Cancer CarePoint Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Recruiting

Industry

Estimated Revenue & Valuation

  • Cancer CarePoint's estimated annual revenue is currently $2.3M per year.(i)
  • Cancer CarePoint's estimated revenue per employee is $84,000

Employee Data

  • Cancer CarePoint has 27 Employees.(i)
  • Cancer CarePoint grew their employee count by -4% last year.

Cancer CarePoint's People

NameTitleEmail/Phone
1
programmerReveal Email/Phone
2
Operations Specialist/Licensing CoordinatorReveal Email/Phone
3
Direct Hire & Locum Tenens Recruitment ConsultantReveal Email/Phone
4
Senior Marketing CoordinatorReveal Email/Phone
5
Operations SpecialistReveal Email/Phone
6
Business Developer/Physician RecruiterReveal Email/Phone
7
Research/ Data/ RecruitingReveal Email/Phone
8
Data EntryReveal Email/Phone
9
Radiation Oncologist RecruiterReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.6M370%N/AN/A
#2
$23.9M18159%N/AN/A
#3
$129.2M769-2%N/AN/A
#4
$52.5M35013%N/AN/A
#5
$3.6M3823%N/AN/A
#6
$3.7M39-2%N/AN/A
#7
$170M101225%N/AN/A
#8
$11.6M975%N/AN/A
#9
$1.2M16-11%N/AN/A
#10
$586.3M39852%N/AN/A
Add Company

What Is Cancer CarePoint?

One Company To Meet All Your Oncology Recruiting Needs. Cancer CarePoint, a certified woman owned small business, is the industry's leading oncology-specific recruiting company offering locum tenens and permanent placement services. We have developed long-standing relationships with thousands of oncology professionals nationwide specializing in physician, allied health, nursing, and administrative director placements. These relationships allow Cancer CarePoint to stay on top of the ever-changing oncology market unlike other companies in the industry.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M27-16%$34.6M
#2
$2.8M270%$162.9M
#3
$3.9M27-10%N/A
#4
$3.1M274%N/A
#5
$5.1M27145%N/A